How UBT251 Affects Birth Control and Stomach Emptying
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a new medicine, UBT251, to see if it affects how birth control pills work and how quickly food leaves the stomach. It is for women with overweight or obesity who cannot get pregnant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman who cannot become pregnant (for example, you have had your tubes tied, a hysterectomy, or are postmenopausal).
- Your body-mass index (BMI) is between 27 and 39.9 (calculated from your height and weight).
- Weigh at least 132 pounds (60 kg).
- Generally healthy aside from being overweight or obese (no major uncontrolled medical conditions).
- Not using certain medications that interfere with the study drug (like weight-loss shots or St. John's Wort).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a new medicine called UBT251 changes how the body processes caffeine, midazolam (a sedative), and warfarin (a blood thinner). It is for generally healthy adults with a Body Mass Index (BMI) between 27 and 40.
This trial tests different doses of UBT251, a new medicine, to see how well it helps people lose weight. It may be an option if you have overweight or obesity and meet certain age and BMI requirements.
This study tests how a new experimental medication (NNC0662-0419) works in women with excess weight who cannot become pregnant. Researchers will also check how it interacts with birth control pills and affects stomach emptying.
This study tests an experimental drug (NNC0487-0111) to see how it changes food intake, appetite, and the way your body processes food after meals. It is for adults with obesity who do not have diabetes.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
This study tests a new drug called BI 3034701 to see how well people tolerate different doses. It may help with weight loss and related health issues.
Hear when a new Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.